Asterias Biotherapeutics (AST) Shares Tick Higher on Positive Mention

September 7, 2016 12:16 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Asterias Biotherapeutics (NYSE: AST) shares are popping to session highs amid a positive mention today by CIRM. The article highlights the benefits of a stem cell clinical trial in helping a spinal cord injury patient regain mobility.

The stock is up over 5 percent.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

FDA, Momentum Movers, Trader Talk

Add Your Comment